Amyloid imaging related abnormalities (ARIA) have now been reported in clinical trials with
multiple therapeutic avenues to lower amyloid-β burden in Alzheimer’s disease (AD). In …

Current research including the basic biology of Alzheimer's disease (AD) provides a
foundation to explore whether our current state of knowledge is sufficient to initiate prevention …

Background Bapineuzumab, a humanized anti–amyloid-beta monoclonal antibody, is in
clinical development for the treatment of Alzheimer's disease. Methods We conducted two …

Objective. —To compare efficacy and safety of tacrine hydrochloride with placebo in
patients with probable Alzheimer's disease. Design. —A 12-week, double-blind, placebo-controlled, …

Background Amyloid-related imaging abnormalities (ARIA) have been reported in patients
with Alzheimer's disease treated with bapineuzumab, a humanised monoclonal antibody …

We investigate the potential of the Kinect depth-mapping camera for sign language recognition
and verification for educational games for deaf children. We compare a prototype Kinect-…

We have examined the location of cholinergic and GABAergic neurons that project to the rat
main olfactory bulb by combining choline acetyltransferase (ChAT) and glutamic acid …

Objective: To assess the safety of galantamine in subjects with mild cognitive impairment (MCI),
the ability of galantamine to benefit cognition and global functioning in subjects with MCI…

Sera from 2 patients with ovarian carcinoma and paraneoplastic cerebellar degeneration
confirmed postmortem were reacted with frozen sections of human cerebellum and stained …

Background Our objective was to evaluate the efficacy (clinical and biomarker) and safety of
intravenous bapineuzumab in patients with mild to moderate Alzheimer’s disease (AD). …